Latest Insider Transactions at Oscar Health, Inc. (OSCR)
This section provides a real-time view of insider transactions for Oscar Health, Inc. (OSCR). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Oscar Health, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Oscar Health, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 01
2021
|
Meghan V. Joyce Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,015
+14.4%
|
-
|
|
Dec 01
2021
|
Dennis Weaver Chief Clinical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,171
+22.68%
|
-
|
|
Sep 16
2021
|
Mario Schlosser President of Technology & CTO |
BUY
Open market or private purchase
|
Direct |
57,300
+49.99%
|
$974,100
$17.53 P/Share
|
|
Sep 15
2021
|
Joshua Kushner Co-Founder and Vice Chairman |
BUY
Open market or private purchase
|
Indirect |
323,725
+6.37%
|
$5,503,325
$17.86 P/Share
|
|
Sep 15
2021
|
Thrive Partners Vii Growth Gp, LLC Director |
BUY
Open market or private purchase
|
Indirect |
323,725
+6.37%
|
$5,503,325
$17.86 P/Share
|
|
Sep 14
2021
|
Joshua Kushner Co-Founder and Vice Chairman |
BUY
Open market or private purchase
|
Indirect |
515,344
+10.42%
|
$9,276,192
$18.1 P/Share
|
|
Sep 14
2021
|
Thrive Partners Vii Growth Gp, LLC Director |
BUY
Open market or private purchase
|
Indirect |
515,344
+10.42%
|
$9,276,192
$18.1 P/Share
|
|
Sep 13
2021
|
Joshua Kushner Co-Founder and Vice Chairman |
BUY
Open market or private purchase
|
Indirect |
377,552
+4.7%
|
$6,418,384
$17.18 P/Share
|
|
Sep 13
2021
|
Thrive Partners Vii Growth Gp, LLC Director |
BUY
Open market or private purchase
|
Indirect |
377,552
+4.7%
|
$6,418,384
$17.18 P/Share
|
|
Sep 10
2021
|
Joshua Kushner Co-Founder and Vice Chairman |
BUY
Open market or private purchase
|
Indirect |
250,000
+6.6%
|
$4,250,000
$17.5 P/Share
|
|
Sep 10
2021
|
Thrive Partners Vii Growth Gp, LLC Director |
BUY
Open market or private purchase
|
Indirect |
250,000
+6.6%
|
$4,250,000
$17.5 P/Share
|
|
Sep 09
2021
|
Joshua Kushner Co-Founder and Vice Chairman |
BUY
Open market or private purchase
|
Indirect |
444,712
+6.53%
|
$7,560,104
$17.46 P/Share
|
|
Sep 09
2021
|
Thrive Partners Vii Growth Gp, LLC Director |
BUY
Open market or private purchase
|
Indirect |
444,712
+6.53%
|
$7,560,104
$17.46 P/Share
|
|
Sep 03
2021
|
Thrive Partners Vii Growth Gp, LLC Director |
BUY
Open market or private purchase
|
Indirect |
157,135
+5.24%
|
$2,828,430
$18.35 P/Share
|
|
Sep 03
2021
|
Joshua Kushner Co-Founder and Vice Chairman |
BUY
Open market or private purchase
|
Indirect |
157,135
+5.24%
|
$2,828,430
$18.35 P/Share
|
|
Sep 02
2021
|
Thrive Partners Vii Growth Gp, LLC Director |
BUY
Open market or private purchase
|
Indirect |
328,351
+5.93%
|
$5,581,967
$17.94 P/Share
|
|
Sep 02
2021
|
Joshua Kushner Co-Founder and Vice Chairman |
BUY
Open market or private purchase
|
Indirect |
328,351
+5.93%
|
$5,581,967
$17.94 P/Share
|
|
Sep 01
2021
|
Dennis Weaver Chief Clinical Officer |
SELL
Open market or private sale
|
Direct |
3,027
-36.25%
|
$51,459
$17.21 P/Share
|
|
Sep 01
2021
|
Dennis Weaver Chief Clinical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,333
+49.95%
|
-
|
|
Sep 01
2021
|
Meghan V. Joyce Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
24,014
-40.92%
|
$408,238
$17.17 P/Share
|
|
Sep 01
2021
|
Meghan V. Joyce Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
58,666
+49.99%
|
-
|
|
Aug 31
2021
|
Joshua Kushner Co-Founder and Vice Chairman |
BUY
Open market or private purchase
|
Indirect |
305,539
+6.21%
|
$4,583,085
$15.12 P/Share
|
|
Aug 31
2021
|
Thrive Partners Vii Growth Gp, LLC Director |
BUY
Open market or private purchase
|
Indirect |
305,539
+6.21%
|
$4,583,085
$15.12 P/Share
|
|
Aug 30
2021
|
Joshua Kushner Co-Founder and Vice Chairman |
BUY
Open market or private purchase
|
Indirect |
329,885
+7.35%
|
$4,618,390
$14.98 P/Share
|
|
Aug 30
2021
|
Thrive Partners Vii Growth Gp, LLC Director |
BUY
Open market or private purchase
|
Indirect |
329,885
+7.35%
|
$4,618,390
$14.98 P/Share
|
|
Aug 27
2021
|
Thrive Partners Vii Growth Gp, LLC Director |
BUY
Open market or private purchase
|
Indirect |
217,590
+11.21%
|
$3,046,260
$14.05 P/Share
|
|
Aug 27
2021
|
Joshua Kushner Co-Founder and Vice Chairman |
BUY
Open market or private purchase
|
Indirect |
217,590
+11.21%
|
$3,046,260
$14.05 P/Share
|
|
Aug 26
2021
|
Thrive Partners Vii Growth Gp, LLC Director |
BUY
Open market or private purchase
|
Indirect |
204,811
+11.98%
|
$2,662,543
$13.74 P/Share
|
|
Aug 26
2021
|
Joshua Kushner Co-Founder and Vice Chairman |
BUY
Open market or private purchase
|
Indirect |
204,811
+11.98%
|
$2,662,543
$13.74 P/Share
|
|
Aug 25
2021
|
Thrive Partners Vii Growth Gp, LLC Director |
BUY
Open market or private purchase
|
Indirect |
31,794
+2.39%
|
$413,322
$13.18 P/Share
|
|
Aug 25
2021
|
Joshua Kushner Co-Founder and Vice Chairman |
BUY
Open market or private purchase
|
Indirect |
31,794
+2.39%
|
$413,322
$13.18 P/Share
|
|
Aug 24
2021
|
Thrive Partners Vii Growth Gp, LLC Director |
BUY
Open market or private purchase
|
Indirect |
1,074,342
+45.85%
|
$12,892,104
$12.69 P/Share
|
|
Aug 24
2021
|
Joshua Kushner Co-Founder and Vice Chairman |
BUY
Open market or private purchase
|
Indirect |
1,074,342
+45.85%
|
$12,892,104
$12.69 P/Share
|
|
Aug 23
2021
|
Thrive Partners Vii Growth Gp, LLC Director |
BUY
Open market or private purchase
|
Indirect |
125,900
+39.3%
|
$1,636,700
$13.01 P/Share
|
|
Aug 23
2021
|
Joshua Kushner Co-Founder and Vice Chairman |
BUY
Open market or private purchase
|
Indirect |
125,900
+39.3%
|
$1,636,700
$13.01 P/Share
|
|
Aug 20
2021
|
Thrive Partners Vii Growth Gp, LLC Director |
BUY
Open market or private purchase
|
Indirect |
68,042
+49.82%
|
$884,546
$13.41 P/Share
|
|
Aug 20
2021
|
Joshua Kushner Co-Founder and Vice Chairman |
BUY
Open market or private purchase
|
Indirect |
68,542
+50.0%
|
$891,046
$13.41 P/Share
|
|
Aug 18
2021
|
Meghan V. Joyce Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
17
+50.0%
|
-
|
|
Aug 18
2021
|
Mario Schlosser President of Technology & CTO |
BUY
Exercise of conversion of derivative security
|
Direct |
17
+50.0%
|
-
|
|
Aug 18
2021
|
Joel Klein Chief Policy & Strat. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
17
+50.0%
|
-
|
|
Aug 18
2021
|
Dennis Weaver Chief Clinical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
17
+50.0%
|
-
|
|
Mar 05
2021
|
Ari Fischel VP, Finance & Accounting |
SELL
Open market or private sale
|
Direct |
6,661
-100.0%
|
$259,779
$39.0 P/Share
|
|
Mar 05
2021
|
Meghan V. Joyce Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
95,394
-100.0%
|
$3,720,366
$39.0 P/Share
|
|
Mar 05
2021
|
Joel Klein Chief Policy & Strat. Officer |
SELL
Open market or private sale
|
Direct |
75,740
-100.0%
|
$2,953,860
$39.0 P/Share
|
|
Mar 05
2021
|
Teri List Director |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+50.0%
|
-
|
|
Mar 05
2021
|
Dennis Weaver Chief Clinical Officer |
SELL
Open market or private sale
|
Direct |
33,333
-100.0%
|
$1,299,987
$39.0 P/Share
|
|
Mar 05
2021
|
David Plouffe |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+50.0%
|
-
|
|
Mar 05
2021
|
Sid Sankaran |
SELL
Open market or private sale
|
Direct |
71,666
-30.07%
|
$2,794,974
$39.0 P/Share
|
|
Mar 05
2021
|
Vanessa Ames Wittman |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+50.0%
|
-
|
|
Mar 05
2021
|
Elbert O. Robinson Jr. |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+50.0%
|
-
|